Table 10.
Summary of calculated BMD/BMDLs for local (forestomach) and systemic (liver and lung) effects using traditional and toxicogenomics approaches. Benchmark response is BMD10/BMDL10 for quantal tumor data and BMD1SD/BMDL1SD for continuous mutations and transcriptional data (mg/kg bw per day).
| Liver | Lung | Forestomach | ||||
|---|---|---|---|---|---|---|
| Approach | BMD/BMDL | Response | BMD/BMDL | Response | BMD/BMDL | Response |
| RA1: Traditional | 1.8 /1.2 | tumors | 0.8* | tumors | 0.8/0.5 | tumors |
| RA1: Mutations | 7.2/4.8 | mutations | 2.2/1.4 | mutations | 0.5/0.3 | mutations |
| RA2/RA3: Toxicogenomics-key event preceeding the committed step | 8.1/1 | DNA damage | 14.8/3.7 | DNA damage | 11.4/7.4 | p53 signaling |
| Toxicogenomics-lowest MOA-associated pathway | 8.1/1 | DNA damage | 14.8/3.7 | DNA damage | 11.4/7.4 | p53 signaling |
| Toxicogenomics-Lowest pathway# | 0.3/0.2 | notch signaling | 15.7/2.1 | cellular effects of sildenafil | 16.1/4.5 | phenylalanine degradationIV |
Caution, based on a LOAEL from coal tar data (Culp et al., 1998)
Similar to Thomas et al., (2011) but examined BMD/BMDLs at the 10th percentile rather than median.